CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib

OBJECTIVES: To analyse the predictive value of the volume of enhancement of disease (VED), based on the CT arterial enhancement coefficient (ΔArt%), in the evaluation of the sorafenib response in patients with advanced hepatocellular carcinoma (HCC). METHODS: Patients with sorafenib-treated advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Colagrande, S., Calistri, L., Campani, C., Dragoni, G., Lorini, C., Nardi, C., Castellani, A., Marra, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Hepatobiliary-Pancreas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880966/
https://www.ncbi.nlm.nih.gov/pubmed/32827266
http://dx.doi.org/10.1007/s00330-020-07171-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880966/
https://www.ncbi.nlm.nih.gov/pubmed/32827266
http://dx.doi.org/10.1007/s00330-020-07171-3

Ejemplares similares